Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Jörg Friedrich Schlaak

Funktionen

  • Nebenberuflich Lehrende/r, Klinik für Gastroenterologie und Hepatologie

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Werner, Melanie; Schefczyk, Stefan; Trippler, Martin; Treckmann, Jürgen-Walter; Baba, Hideo Andreas; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3
    In: Viruses, Jg. 14, 2022, Nr. 2, 218
    DOI (Open Access)
  • Zhang, Zhenhua; Trippler, Martin; Real, Catherine I.; Werner, Melanie; Luo, Xufeng; Schefczyk, Stefan; Kemper, Thekla; Anastasiou, Olympia E.; Ladiges, Yvonne; Treckmann, Jürgen-Walter; Paul, Andreas; Baba, Hideo Andreas; Allweiss, Lena; Dandri, Maura; Gerken, Guido; Wedemeyer, Heiner; Schlaak, Jörg Friedrich; Lu, Mengji; Bröring, Ruth
    Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes
    In: Hepatology, Jg. 72, 2020, Nr. 3, S. 829 – 844
    DOI (Open Access)
  • Chauhan, Nikhil; Bukovcan, Janet; Boucher, Eveline; Edeline, Julien; Hamilton, Bonnie; Kulik, Laura; Master, Fayaz; Salem, Riad; Kevin Kim, H.; El-Rayes, Bassel; Schlaak, Jörg Friedrich; Cohen, Stephen; Raoul, Jean-Luc; Strosberg, Jonathan; Arslan, Bulent; Shridhar, Ravi; Johnson, Matt; Maluccio, Mary; Brown, Dan; Geschwind, Jeff; Cosgrove, David; Choti, Michael; Zhu, Andrew; Roberts, Lewis; Rilling, Bill; Murthy, Ravi; Kaseb, Ahmed; Mazzaferro, Vincenzo; Mulcahy, Mary; Lewandowski, Bob; Benson, Al; Bloomston, Mark; Saab, Tony; Khabiri, Hooman; Sze, Daniel; Messersmith, Wells; Durham, Jan; Fidelman, Nicholas; Zhao, HuaChing
    Intra-arterial TheraSphere yttrium-90 glass microspheres in the treatment of patients with unresectable hepatocellular carcinoma : Protocol for the STOP-HCC phase 3 randomized controlled trial
    In: Journal of Medical Internet Research (JMIR), Jg. 20, 2018, Nr. 8, S. e11234
    DOI (Open Access)
  • Real, Catherine Isabell; Werner, Melanie; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich; Vaillant, Andrew; Bröring, Ruth
    Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells
    In: Scientific Reports, Jg. 7, 2017, S. 43838
    DOI (Open Access)
  • Megger, Dominik Andre; Rosowski, Kristin; Ahrens, Maike; Bracht, Thilo; Eisenacher, Martin; Schlaak, Jörg Friedrich; Weber, Frank; Hoffmann, Andreas-Claudius; Meyer, Helmut E.; Baba, Hideo Andreas; Sitek, Barbara
    Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tags
    In: Biomarkers, Jg. 22, 2017, Nr. 2, S. 113 – 122
    DOI
  • Petersen, Jörg; Hueppe, Dietrich; Warger, Tobias; Ruppert, Susanne; Krause, Wolfgang; Trein, Andreas; Felten, Gisela; Trautwein, Christian; Leuschner, Maria; John, Christine; Loehr, Hanns-Friedrich; Boeker, Klaus; Wiese, Manfred; Hartmann, Heinz; Eisenbach, Christoph; Schiffelholz, Willibald; Schlaak, Jörg Friedrich; Mauss, Stefan; Heyne, Renate
    Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B : A 3-Year Prospective Field Practice Study in Germany
    In: Digestive Diseases and Sciences, Jg. 61, 2016, Nr. 10, S. 3061 – 3071
    DOI
  • Bröring, Ruth; Trippler, Martin; Werner, Marc; Real, Catherine Isabell; Megger, Dominik A.; Bracht, Thilo; Schweinsberg, Vincent; Sitek, Barbara; Eisenacher, Martin; Meyer, Helmut Erich; Baba, Hideo Andreas; Weber, Frank; Hoffmann, Andreas-Claudius; Gerken, Guido; Schlaak, Jörg Friedrich
    Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of ISG15 ubiquitin-like modifier, a proviral host gene in hepatitis C virus infection
    In: Journal of Viral Hepatitis, Jg. 23, 2016, Nr. 5, S. 375 – 386
    DOI
  • Real, Catherine Isabell; Bröring, Ruth; Schlaak, Jörg Friedrich; Gerken, Guido; Schirmbeck, Reinhold; Vornlocher, Hans-Peter; Dittmer, Ulf; Gibbert, Kathrin; John, Matthias Johannes; Ickenstein, Ludger Markus; Jahn-Hofmann, Kerstin; Deckert, Jochen; Hossbach, Markus; Trippler, Martin; Huang, Xuan; Lu, Mengji; Liu, Jia
    Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen
    In: Scientific Reports, Jg. 6, 2016, S. 24865
    DOI (Open Access)
  • Bertram, Stefanie; Padden, Juliet; Kälsch, Julia; Ahrens, Maike; Pott, Leona; Canbay, Aliekber; Weber, Frank; Fingas, Christian; Hoffmann, Andreas-Claudius; Vietor, Antonie; Schlaak, Jörg Friedrich; Eisenacher, Martin; Reis, Henning; Sitek, Barbara; Baba, Hideo Andreas
    Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions
    In: Journal of Clinical Pathology: JCP Online, Jg. 69, 2016, Nr. 7, S. 619 – 626
    DOI
  • Levy, Gahl; Habib, Naomi; Guzzardi, Maria Angela; Kitsberg, Daniel; Bomze, David; Ezra, Elishai; Uygun, Basak E; Uygun, Korkut; Trippler, Martin; Schlaak, Jörg Friedrich; Shibolet, Oren; Sklan, Ella H; Cohen, Merav; Timm, Jörg; Friedman, Nir; Nahmias, Yaakov
    Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection
    In: Nature Chemical Biology, Jg. 12, 2016, Nr. 12, S. 1037 – 1045
    DOI
  • Naboulsi, Wael; Megger, Dominik A.; Bracht, Thilo; Kohl, Michael; Turewicz, Michael; Eisenacher, Martin; Voss, Don Marvin; Schlaak, Jörg Friedrich; Hoffmann, Andreas-Claudius; Weber, Frank; Baba, Hideo Andreas; Meyer, Helmut E.; Sitek, Barbara
    Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma
    In: Journal of Proteome Research, Jg. 15, 2016, Nr. 1, S. 38 – 47
    DOI
  • Berhane, Sarah; Toyoda, Hidenori; Tada, Toshifumi; Kumada, Takashi; Kagebayashi, Chiaki; Satomura, Shinji; Schweitzer, Nora; Vogel, Arndt; Manns, Michael P; Benckert, Julia; Berg, Thomas; Ebker, Maria; Best, Jan; Dechene, Alexander; Gerken, Guido; Schlaak, Jörg Friedrich; Weinmann, Arndt; Wörns, Marcus A; Galle, Peter; Yeo, Winnie; Mo, Frankie; Chan, Stephen L; Reeves, Helen; Cox, Trevor; Johnson, Philip
    Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
    In: Clinical Gastroenterology and Hepatology, Jg. 14, 2016, Nr. 6, S. 875 – 886.e6
    DOI
  • Reis, Henning; Pütter, Carolin; Megger, Dominik A.; Bracht, Thilo; Weber, Frank; Hoffmann, Andreas-Claudius; Bertram, Stefanie; Wohlschläger, Jeremias; Hagemann, Sascha; Eisenacher, Martin; Scherag, André; Schlaak, Jörg Friedrich; Canbay, Aliekber; Meyer, Helmut E.; Sitek, Barbara; Baba, Hideo Andreas
    A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors
    In: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Jg. 1854, 2015, Nr. 6, S. 641 – 650
    DOI
  • Werner, Melanie; Driftmann, Sabrina; Kleinehr, Kathrin; Kaiser, Gernot Maximil; Mathe, Zoltan; Treckmann, Jürgen-Walter; Paul, Andreas; Skibbe, Kathrin; Timm, Jörg; Canbay, Aliekber; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    All-In-One : Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells
    In: PLoS ONE, Jg. 10, 2015, Nr. 9, S. e0138655
    DOI (Open Access)
  • Bracht, Thilo; Schweinsberg, Vincent; Trippler, Martin; Kohl, Michael; Ahrens, Maike; Padden, Juliet; Naboulsi, Wael; Barkovits, Katalin; Megger, Dominik A; Eisenacher, Martin; Borchers, Christoph H; Schlaak, Jörg Friedrich; Hoffmann, Andreas-Claudius; Weber, Frank; Baba, Hideo Andreas; Meyer, Helmut E; Sitek, Barbara
    Analysis of disease-associated protein expression using quantitative proteomics : fibulin-5 is expressed in association with hepatic fibrosis
    In: Journal of Proteome Research, Jg. 14, 2015, Nr. 5, S. 2278 – 2286
    DOI
  • Werner, M.; Driftmann, S.; Kleinehr, K.; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    Antiviral activity of human Kupffer cells, liver sinusoidal endothelial cells and hepatic stellate cells against Hepatitis C virus is restricted to toll-like receptor 3 stimulation and involves type I interferons
    In: Journal of Viral Hepatitis, Jg. 22, 2015, Nr. S2, S. 71 – 72
    DOI
  • Lutterbeck, M.; Driftmann, S.; Kleinehr, K.; Paul, A.; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    Antiviral activity of human non-parenchymal liver cells is restricted to toll-like receptor 3 and involves type I interferons
    In: Journal of Hepatology, Jg. 62, 2015, Nr. Suppl. 2, S. 587
    DOI
  • Reis, Henning; Padden, Juliet; Ahrens, Maike; Pütter, Carolin; Bertram, Stefanie; Pott, Leona L; Reis, Anna-Carinna; Weber, Frank; Juntermanns, Benjamin; Hoffmann, Andreas-Claudius; Eisenacher, Martin; Schlaak, Jörg Friedrich; Canbay, Aliekber; Meyer, Helmut E; Sitek, Barbara; Baba, Hideo Andreas
    Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomas
    In: Pathology, Jg. 47, 2015, Nr. 6, S. 543 – 550
    DOI
  • Bröring, Ruth; Trippler, M.; Werner, M.; Real, C. I.; Megger, D. A.; Bracht, T.; Schweinsberg, V.; Sitek, B.; Eisenacher, M.; Meyer, H. E.; Baba, Hideo Andreas; Weber, F.; Hoffmann, A. C.; Gerken, Guido; Schlaak, Jörg Friedrich
    Hepatic expression of proteasome subunit alpha type-6 is upregulated during viral hepatitis and putatively regulates the expression of proviral host genes in hepatitis C virus infectio
    In: Journal of Viral Hepatitis, Jg. 22, 2015, Nr. S 2, S. 71
    DOI
  • El Fouly, Amr; Ertle, Judith; El Dorry, Ahmed; Shaker, Mohamed K; Dechene, Alexander; Abdella, Heba; Müller, Stefan; Barakat, Eman; Lauenstein, Thomas; Bockisch, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    In intermediate stage hepatocellular carcinoma : radioembolization with yttrium 90 or chemoembolization?
    In: Liver International, Jg. 35, 2015, Nr. 2, S. 627 – 635
    DOI
  • Zhang, Zhenhua; Xia, Jianbo; Sun, Binghu; Dai, Yu; Li, Xu; Schlaak, Jörg Friedrich; Lu, Mengji
    In vitro and in vivo replication of a chemically synthesized consensus genome of hepatitis B virus genotype B
    In: Journal of Virological Methods, Jg. 213, 2015, S. 57 – 64
    DOI
  • Grüner, Nico; Viazov, Sergey; Korn, Klaus; Knöll, Antje; Trippler, Martin; Schlaak, Jörg Friedrich; Gerken, Guido; Roggendorf, Michael; Roß, Rudolf Stefan
    Performance characteristics of the VERSANT hepatitis C virus RNA 1.0 (kPCR) assay
    In: International Journal of Medical Microbiology (IJMM), Jg. 305, 2015, Nr. 7, S. 627 – 635
    DOI
  • Bröring, Ruth; Trippler, M.; Lutterbeck, M.; Real, C. I.; Megger, D. A.; Bracht, T.; Schweinsberg, V.; Sitek, B.; Eisenacher, M.; Meyer, H. E.; Baba, Hideo Andreas; Weber, F.; Hoffmann, A. C.; Gerken, Guido; Schlaak, Jörg Friedrich
    Proteasome subunit alpha type-6 regulates the expression of proviral host genes in hepatitis C virus infection
    In: Journal of Hepatology, Jg. 62, 2015, Nr. Suppl. 2, S. 583 – S583
    DOI
  • Hoyo-Becerra, Carolina; Liu, Zijian; Yao, Jinghong; Kaltwasser, Britta; Gerken, Guido; Hermann, Dirk M.; Schlaak, Joerg F.
    Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection
    In: Molecular Neurobiology, Jg. 52, 2015, Nr. 1, S. 318 – 329
    DOI
  • Real, C. I.; Lu, M.; Hossbach, M.; Deckert, J.; Jahn-Hofmann, K.; Ickenstein, L. M.; John, M. M.; Trippler, M.; Gibbert, K.; Dittmer, Ulf; Vornlocher, H. P.; Schirmbeck, R.; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    The hepatitis B virus (HBV) surface antigen (HBsAg) prevents hepadnaviral replication-dependent interferon responses, which are mediated by non-parenchymal liver cells in a HBV transgenic mouse model
    In: Journal of Viral Hepatitis, Jg. 22, 2015, Nr. S2, S. 29 – 30
    DOI
  • Real, C. I.; Lu, M.; Hossbach, M.; Deckert, J.; Jahn-Hofmann, K.; Ickenstein, L. M.; John, M. J.; Trippler, M.; Gibbert, K.; Dittmer, U.; Vornlocher, H. P.; Schirmbeck, R.; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    The hepatitis B virus (HBV) surface antigen impedes hepadnaviral replication-dependent interferon responses in a HBV transgenic mouse model
    In: Journal of Hepatology, Jg. 62, 2015, Nr. Suppl. 2, S. 286
    DOI
  • Berhane, S.; Toyoda, H.; Tada, T.; Kumada, T.; Kagebayashi, C.; Satomura, S.; Schweitzer, N.; Vogel, A.; Manns, M.; Benckert, J.; Berg, T.; Best, Jan; Dechene, Alexander; Gerken, Guido; Schlaak, Jörg Friedrich; Reeves, H. L.; Johnson, P.
    The ‘GALAD score’ for serological detection of hepatocellular carcinoma : International validation and assessment of the influence of tumour size and aetiology on model utility
    In: Journal of Hepatology, Jg. 62, 2015, Nr. Suppl. 2, S. 434
    DOI
  • Noordeen, Faseeha; Jilbert, Allison R.; Vaillant, Andrew; Schlaak, Jörg Friedrich; Bröring, Ruth; Werner, Melanie; Finnie, John; Reaiche-Miller, Georget; Ajilian, Behzad B.; Qiao, Qiao; Grosse, Arend; Scougall, Catherine A.
    Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection
    In: PLoS ONE, Jg. 10, 2015, Nr. 11, S. e0140909
    DOI (Open Access)
  • Kohl, Michael; Megger, Dominik A.; Trippler, Martin; Meckel, Hagen; Ahrens, Maike; Bracht, Thilo; Weber, Frank; Hoffmann, Andreas-Claudius; Baba, Hideo Andreas; Sitek, Barbara; Schlaak, Jörg Friedrich; Meyer, Helmut E.; Stephan, Christian; Eisenacher, Martin
    A practical data processing workflow for multi-OMICS projects
    In: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Jg. 1844, 2014, Nr. 1 Part A, S. 52 – 62
    DOI (Open Access)
  • Baraniskin, A.; Nöpel-Dünnebacke, S.; Schumacher, B.; Gerges, C.; Bracht, T.; Sitek, B.; Meyer, H. E.; Gerken, Guido; Dechene, Alexander; Schlaak, Jörg Friedrich; Schroers, R.; Pox, C.; Schmiegel, W.; Hahn, S. A.
    Analysis of U2 Small Nuclear RNA Fragments in the Bile Differentiates Cholangiocarcinoma from Primary Sclerosing Cholangitis and Other Benign Biliary Disorders
    In: Digestive Diseases and Sciences, Jg. 59, 2014, Nr. 7, S. 1436 – 1441
    DOI
  • Bröring, Ruth; Real, Catherine; John, Matthias J.; Jahn-Hofmann, Kerstin; Ickenstein, Ludger M.; Kleinehr, Kathrin; Paul, Andreas; Sutter, Kathrin; Dittmer, Ulf; Gerken, Guido; Schlaak, Jörg Friedrich
    Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro
    In: International Immunology, Jg. 26, 2014, Nr. 1, S. 35 – 46
    DOI
  • Theysohn, Jens; Ertle, Judith; Müller, Stefan; Schlaak, Jörg Friedrich; Nensa, Felix; Sipilae, S.; Bockisch, Andreas; Lauenstein, Thomas
    Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma
    In: Clinical Radiology, Jg. 69, 2014, Nr. 2, S. 172 – 178
    DOI
  • Nel, Ivonne; Baba, Hideo Andreas; Weber, Frank; Sitek, Barbara; Eisenacher, Martin; Meyer, Helmut E.; Schlaak, Jörg Friedrich; Hoffmann, Andreas-Claudius
    IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma
    In: Biomarkers in Medicine, Jg. 8, 2014, Nr. 5, S. 687 – 698
    DOI
  • Padden, Juliet; Megger, Dominik A; Bracht, Thilo; Reis, Henning; Ahrens, Maike; Kohl, Michael; Eisenacher, Martin; Schlaak, Jörg Friedrich; Canbay, Aliekber; Weber, Frank; Hoffmann, Andreas-Claudius; Kuhlmann, Katja; Meyer, Helmut E; Baba, Hideo Andreas; Sitek, Barbara
    Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma
    In: Molecular and Cellular Proteomics (MCP), Jg. 13, 2014, Nr. 10, S. 2661 – 2672
    DOI
  • Hoyo-Becerra, Carolina; Schlaak, Jörg Friedrich; Hermann, Dirk M.
    Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
    In: Brain, Behavior and Immunity, Jg. 42, 2014, S. 222 – 231
    DOI
  • Katsounas, Antonios; Rasimas, Joseph J; Schlaak, Jörg Friedrich; Lempicki, Richard A; Rosenstein, Donald L; Kottilil, Shyam
    Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients
    In: Journal of Medical Virology, Jg. 86, 2014, Nr. 8, S. 1323 – 1331
    DOI, Online Volltext (Open Access)
  • Pei, Ronjuan; Qin, Bo; Zhang, Xiaoyong; Zhu, Wandi; Kemper, Thekla; Ma, Zhiong; Trippler, Martin; Schlaak, Jörg Friedrich; Chen, Xinwen; Lu, Mengji
    Interferon-induced proteins with tetratricopeptide repeats 1 and 2 are cellular factors that limit hepatitis B virus replication
    In: Journal of Innate Immunity, Jg. 6, 2014, Nr. 2, S. 182 – 191
    DOI
  • Tucci, Felicia A.; Bröring, Ruth; Lutterbeck, Melanie; Schlaak, Jörg Friedrich; Küppers, Ralf
    Intrahepatic B-cell follicles of chronically hepatitis C virus-infected individuals lack signs of an ectopic germinal center reaction
    In: European Journal of Immunology, Jg. 44, 2014, Nr. 6, S. 1842 – 1850
    DOI
  • Thoens, Christine; Berger, Christoph; Trippler, Martin; Siemann, Holger; Lutterbeck, M.; Bröring, Ruth; Schlaak, Jörg Friedrich; Heinemann, Falko M.; Heinold, Andreas; Nattermann, Jacob; Scherbaum, Norbert; Alter, Galit; Timm, Jörg
    KIR2DL3+NKG2A− natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs
    In: Journal of Hepatology, Jg. 61, 2014, Nr. 3, S. 475 – 481
    DOI
  • Schlaak, Jörg Friedrich
    Labordiagnostik bei primärem Leberzellkarzinom
    In: Der Gastroenterologe, Jg. 9, 2014, Nr. 2, S. 138 – 144
    DOI
  • Bröring, Ruth; Lutterbeck, M.; Trippler, M.; Kleinehr, K.; Poggenpohl, L.; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I : C treatment
    In: Journal of Viral Hepatitis, Jg. 21, 2014, Nr. 7, S. 480 – 490
    DOI
  • Jiang, M.; Bröring, Ruth; Trippler, M.; Wu, J.; Zhang, E.; Zhang, X.; Gerken, Guido; Lu, Mengji; Schlaak, Jörg Friedrich
    MicroRNA-155 controls Toll-like receptor 3- and hepatitis C virus-induced immune responses in the liver
    In: Journal of Viral Hepatitis, Jg. 21, 2014, Nr. 2, S. 99 – 110
    DOI
  • Hilgard, Philip Alexander; Dechene, Alexander; Canbay, Aliekber; Herzer, Kerstin; Schlaak, Jörg Friedrich; Treichel, Ulrich; Gassel, Andrea M.; Baba, Hideo Andreas; Zöpf, Thomas
    Mini-laparoscopy is superior in detecting liver cirrhosis and metastases in liver cancer : an over 10-year experience in 1,788 cases
    In: Digestion, Jg. 89, 2014, Nr. 2, S. 156 – 164
    DOI
  • Wu, Jun; Huang, Shunmei; Zhao, Xiaoli; Chen, Minfei; Lin, Yong; Xia, Youchen; Sun, Chan; Yang, Xuecheng; Wang, Junzhong; Guo, Yan; Song, Jingjiao; Zhang, Ejuan; Wang, Baoju; Zheng, Xin; Schlaak, Jörg Friedrich; Lu, Mengji; Yang, Dongliang
    Poly(I:C) Treatment Leads to Interferon-Dependent Clearance of Hepatitis B Virus in a Hydrodynamic Injection Mouse Model
    In: Journal of Virology, Jg. 88, 2014, Nr. 18, S. 10421 – 10431
    DOI
  • Nel, Ivonne; David, Paul; Gerken, Guido; Schlaak, Jörg Friedrich; Hoffmann, Andreas-Claudius
    Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma
    In: Hepatology International, Jg. 8, 2014, Nr. 3, S. 321 – 329
    DOI
  • Schelhorn, Juliane; Ertle, Judith; Schlaak, Jörg Friedrich; Mueller, Stefan; Bokisch, Andreas; Schlosser, Thomas Wilfried; Lauenstein, Thomas
    Selective internal radiation therapy of hepatic tumors : procedural implications of a patent hepatic falciform artery
    In: SpringerPlus, Jg. 3, 2014, Nr. 1, 595
    DOI (Open Access)
  • Schelhorn, J.; Theysohn, Jens; Ertle, Judith; Schlaak, Jörg Friedrich; Müller, Stefan; Bockisch, Andreas; Lauenstein, Thomas
    Selective internal radiation therapy of hepatic tumours : Is coiling of the gastroduodenal artery always beneficial?
    In: Clinical Radiology, Jg. 69, 2014, Nr. 5, S. e216 – e222
    DOI
  • Buechter, M.; Klein, Christian Georg; Kloeters, C.; Schlaak, Jörg Friedrich; Canbay, Aliekber; Gerken, Guido; Kahraman, Alisan
    Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis
    In: Zeitschrift für Gastroenterologie, Jg. 52, 2014, Nr. 6, S. 564 – 568
    DOI
  • Real, C. I.; Lu, M. J.; Hossbach, M.; Jahn-Hofmann, K.; Ickenstein, L. M.; John, M. J.; Vornlocher, H. P.; Schirmbeck, R.; Lutterbeck, M.; Gibbert, K.; Dittmer, Ulf; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    Toll-like receptor 3-acivated non-parenchymal liver cells control hepadnaviral replication in HBV-transgenic mice lacking the surface antigen (HBsAg)
    In: Hepatology, Jg. 60, 2014, Nr. Suppl. 1, S. 1022A
    DOI (Open Access)
  • Jiang, M; Bröring, Ruth; Trippler, M; Poggenpohl, L; Fiedler, Melanie; Gerken, Guido; Lu, Mengji; Schlaak, Jörg Friedrich
    Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen
    In: Journal of Viral Hepatitis, Jg. 21, 2014, Nr. 12, S. 860 – 872
    DOI
  • Weng, Zhihong; Ertle, Judith; Zheng, Shaoping; Lauenstein, Thomas; Müller, Stefan; Bockisch, Andreas; Gerken, Guido; Yang, Dongliang; Schlaak, Jörg Friedrich
    A New Model to Estimate Prognosis in Patients with Hepatocellular Carcinoma after Yttrium-90 Radioembolization
    In: PLoS ONE, Jg. 8, 2013, Nr. 12, S. 0082225
    DOI (Open Access)
  • Ertle, Judith; Heider, Dominik; Wichert, Marc; Keller, Benedikt; Kueper, Robert; Hilgard, Philip Alexander; Gerken, Guido; Schlaak, Jörg Friedrich
    A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma
    In: Digestion, Jg. 87, 2013, Nr. 2, S. 121 – 131
    DOI
  • Padden, J.; Schlaak, Jörg Friedrich; Meyer, H.E.; Kohl, M.; Bracht, T.; Gerges, C.; Baba, Hideo Andreas; Tautges, S.; Megger, D.A.; Eisenacher, M.; Sitek, B.
    A proteomic study of cholangiocellular carcinoma for detection of novel biomarkers in the bile
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S438
    DOI
  • Tucci, Felicia Anna; Bröring, Ruth; Johansson, Patricia; Schlaak, Jörg Friedrich; Küppers, Ralf
    B Cells in Chronically Hepatitis C Virus-Infected Individuals Lack a Virus-Induced Mutation Signature in the TP53, CTNNB1, and BCL6 Genes
    In: Journal of Virology, Jg. 87, 2013, Nr. 5, S. 2956 – 2962
    DOI
  • Weng, Zhihong; Ertle, Judith; Zheng, Shaoping; Lauenstein, Thomas; Müller, Stefan; Bockisch, Andreas; Gerken, Guido; Yang, Dongliang; Schlaak, Jörg Friedrich
    Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma
    In: Oncology Letters, Jg. 6, 2013, Nr. 6, S. 1707 – 1712
    DOI
  • Hoyo-Becerra, Carolina; Huebener, Anastasia; Trippler, Martin; Lutterbeck, Melanie; Liu, Zijian J.; Trübner, Kurt; Bajanowski, Thomas; Gerken, Guido; Hermann, Dirk M.; Schlaak, Jörg Friedrich
    Concomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons
    In: PLoS ONE, Jg. 8, 2013, Nr. 12, S. e83149
    DOI (Open Access)
  • Petersen, J.; Heyne, R.; Mauss, S.; Schlaak, Jörg Friedrich; Schiffelholz, W.; Eisenbach, C.; Hartmann, H.; Wiese, M.; Boeker, K.; Loehr, H. F.; John, C.; Leuschner, M.; Trautwein, C.; Felten, G.; Trein, A.; Krause, W.; Ruppert, S.; Warger, T.; Huppe, D.; GEMINIS
    Effectiveness of tenofovir for chronic Hepatitis B in field practice-2 year interim results from the prospective german multicenter non-interventional study (Geminis)
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. 313
  • Katsounas, Antonios; Hubbard, Jonathan J.; Wang, Crystal H.; Zhang, Xiaozhen; Dou, Diana; Shivakumar, Bhavana; Winter, Sophie; Schlaak, Jörg Friedrich; Lempicki, Richard A.; Masur, Henry; Polis, Michael; Kottilil, Shyam; Osinusi, Anu
    High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV
    In: Journal of Medical Virology, Jg. 85, 2013, Nr. 6, S. 959 – 963
    DOI
  • Gibbert, K.; Schlaak, Jörg Friedrich; Yang, D.; Dittmer, Ulf; Schlaak, JF
    IFN-α subtypes : Distinct biological activities in anti-viral therapy
    In: British Journal of Pharmacology (BJP), Jg. 168, 2013, Nr. 5, S. 1048 – 1058
    DOI (Open Access)
  • Real, Catherine I.; Megger, Dominik A.; Sitek, Barbara; Jahn-Hofmann, Kerstin; Ickenstein, Ludger M.; John, Matthias J.; Walker, Andreas; Timm, Jörg; Kuhlmann, Katja; Eisenacher, Martin; Meyer, Helmut E.; Gerken, Guido; Bröring, Ruth; Schlaak, Jörg Friedrich
    Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication
    In: Antiviral Research, Jg. 100, 2013, Nr. 3, S. 654 – 661
    DOI
  • Nel, Ivonne; Baba, Hideo Andreas; Ertle, Judith; Weber, Frank; Sitek, Barbara; Eisenacher, Martin; Meyer, Helmut E.; Schlaak, Jörg Friedrich; Hoffmann, Andreas-Claudius
    Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma
    In: Translational Oncology, Jg. 6, 2013, Nr. 4, S. 420 – 428
    DOI
  • Gerken, Guido; Bockisch, Andreas; Mueller, S.; Dechene, Alexander; Schlaak, Jörg Friedrich; Lauenstein, Thomas; El Fouly, A.; Ertle, Judith
    Long term clinical and biochemical comparative analysis after selective internal radiotherapy with yttrium-90 microspheres in hepatocellular carcinoma
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S109
    DOI
  • Schuchmann, Marcus; Kittner, Jens M.; Schlaak, Jörg Friedrich; Klass, Dietmar M.; Eisenbach, Christoph; Berg, Thomas; Trautwein, Christian; Günther, Rainer; Zeuzem, Stefan; Gösseringer, Roger; Ehrlich, Anne; Neumann, Konrad; Wachtlin, Daniel; Sprinzl, Martin F.; Zimmermann, Tim; Böcher, Wulf O.; Galle, Peter R.
    No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C : The ATRACTION study, a phase II randomised trial
    In: Digestive and Liver Disease, Jg. 45, 2013, Nr. 4, S. 323 – 329
    DOI
  • Radunz, S.; Benko, T.; Schlaak, Jörg Friedrich; Bockisch, Andreas; Lauenstein, Thomas; Baba, Hideo Andreas; Paul, Andreas; Treckmann, Jürgen-Walter
    Pre-transplant treatment of hepatocellular carcinoma with radioembolization using yttrium-90 microspheres
    In: Transplant International, Jg. 26, 2013, Nr. Suppl. 2, S. 64
  • Megger, Dominik A.; Bracht, Thilo; Kohl, Michael; Ahrens, Maike; Naboulsi, Wael; Weber, Frank; Hoffmann, Andreas-Claudius; Stephan, Christian; Kuhlmann, Katja; Eisenacher, Martin; Schlaak, Jörg Friedrich; Baba, Hideo Andreas; Meyer, Helmut E.; Sitek, Barbara
    Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study
    In: Molecular and Cellular Proteomics (MCP), Jg. 12, 2013, Nr. 7, S. 2006 – 2020
    DOI
  • Gerken, Guido; Trippler, M.; Kleinehr, K.; Paul, Andreas; Bröring, Ruth; Schlaak, Jörg Friedrich; Lutterbeck, M.
    Repetitive actication of toll-like receptor 3 in primary human hepatocytes leads to hyper-responsiveness to poly : in vitro
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S144 – S145
    DOI
  • Lang, Hauke; Ricke, Jens; Schlaak, Jörg Friedrich
    Resektion oder lokal-ablative Therapie bei hepatozellulärem Karzinom : welche Methode für welche Patienten?
    In: Deutsche Medizinische Wochenschrift - DMW, Jg. 138, 2013, Nr. 36, S. 1780 – 1784
    DOI
  • Theysohn, Jens M.; Müller, Stefan; Schlaak, Jörg Friedrich; Ertle, Judith; Schlosser, Thomas Wilfried; Bockisch, Andreas; Lauenstein, Thomas C.
    Selective Internal Radiotherapy (SIRT) of Hepatic Tumors : How to Deal with the Cystic Artery
    In: Cardiovascular and Interventional Radiology, Jg. 36, 2013, Nr. 4, S. 1015 – 1022
    DOI
  • Liu, Jia; Jiang, Min; Ma, Zhiyong; Dietze, Kirsten; Zelinskyy, Gennadiy; Yang, Dongliang; Dittmer, Ulf; Schlaak, Jörg Friedrich; Roggendorf, Michael; Lu, Mengji
    TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro
    In: The Journal of Immunology (JI), Jg. 191, 2013, Nr. 12, S. 6178 – 6190
    DOI
  • Real, C. I.; Bröring, Ruth; Kleinehr, K.; Driftmann, S.; Schirmbeck, R.; Lu, M.; Gerken, Guido; Schlaak, Jörg Friedrich
    The pro-inflammatory response induced by toll-like receptor activation in vivo is not impaired in the liver of HBV-transgenic mice lacking HBsAg
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. 163
  • Paul, Andreas; Schlaak, Jörg Friedrich; Kleinehr, K.; Bröring, Ruth; Lutterbeck, M.; Guido, G.
    Toll-like receptor 3 stimulated primary human non-parenchymal liver cells are potent suppressors of Hepatitis C virus replication
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. S145
    DOI
  • Gu, Yanli; Sowa, Jan-Peter; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    Vascular endothelial growth factor improves liver regeneration and survival after 90% hepatectomy in a rat model of diet-induced steatosis
    In: Digestion, Jg. 88, 2013, Nr. 4, S. 235 – 242
    DOI
  • Real, C. I.; Bröring, Ruth; Trippler, M.; Jahn-Hofmann, K.; Ickenstein, L.; John, M.; Kleinehr, K.; Driftmann, S.; Kemper, T.; Vornlocher, H. P.; Schirmbeck, R.; Lu, M.; Gerken, Guido; Schlaak, Jörg Friedrich
    Viral replication in HBV-transgenic mice lacking the HBsAg significantly induces interferon responses
    In: Journal of Hepatology, Jg. 58, 2013, Nr. Suppl. 1, S. 163
  • Wang, B.; Real, C. I.; Lutterbeck, M.; Bröring, Ruth; Gerken, Guido; Lu, M. J.; Schlaak, Jörg Friedrich
    Activation by pathogen- and damage-associated molecular patterns regulates the expression of RANTES in primary hepatic stellate cells
    In: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 767A
  • Real, C. I.; Bröring, Ruth; Jahn-Hofmann, K.; Ickenstein, L.; John, M.; Kleinehr, K.; Gerken, Guido; Schlaak, Jörg Friedrich
    Application of LNP01-formulated sirnas in vivo activates hepatic toll-like receptors via MYD88-dependent pathways which can be controlled by chemical ribose modifications
    In: Journal of Hepatology, Jg. 56, 2012, Nr. Suppl. 2, S. 315
  • Katsounas, Antonios; Trippler, M.; Wang, B.; Polis, M.; Lempicki, R. A.; Kottilil, S.; Gerken, Guido; Schlaak, Jörg Friedrich
    CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signalling
    In: Journal of Viral Hepatitis, Jg. 19, 2012, Nr. 2, S. 128 – 137
    DOI
  • Hoyo-Becerra, C.; Hubener, A.; Trippler, M.; Poggenpohl, L.; Gerken, Guido; Schlaak, Jörg Friedrich
    Characterization of Interferon-alpha and Poly I : C Regulation of Interferon-Inducible Genes in Hippocampal and Prefrontal Cortex Neurons
    In: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 702A – 702A
  • Katsounas, Antonios; Trippler, Martin; Kottilil, Shyam; Lempicki, Richard A.; Gerken, Guido; Schlaak, Jörg Friedrich
    Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C
    In: European Journal of Medical Research, Jg. 17, 2012, Nr. 1, S. 9
    DOI, Online Volltext (Open Access)
  • Naggie, Susanna; Osinusi, Anu; Katsounas, Antonios; Lempicki, Richard; Herrmann, Eva; Thompson, Alexander J.; Clark, Paul J.; Patel, Keyur; Muir, Andrew J.; McHutchison, John G.; Schlaak, Jörg Friedrich; Trippler, Martin; Shivakumar, Bhavana; Masur, Henry; Polis, Michael A.; Kottilil, Shyam
    Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients : impaired viral kinetics and therapeutic response
    In: Hepatology, Jg. 56, 2012, Nr. 2, S. 444 – 454
    DOI
  • Jiang, M.; Trippler, M.; Broring, R.; Poggenpohl, L.; Gerken, Guido; Lu, M. J.; Schlaak, Jörg Friedrich
    Hepatitis B Virus Surface Antigen Suppresses Innate and Adaptive Immune Responses of Murine and Human Liver Cells
    In: Gastroenterology, Jg. 142, 2012, Nr. 5, Suppl. 1, S. 990
  • Broring, R.; Lutterbeck, M.; Kleinehr, K.; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    Human Hepatocytes Produce Inflammatory Cytokines and Type I, II and III Interferons in Response to Toll-Like Receptor Activation, Resulting in IFN-lambda-Mediated Suppression of HCV In Vitro
    In: Gastroenterology, Jg. 142, 2012, Nr. 5, Suppl. 1, S. 989
  • Real, C. I.; Bröring, Ruth; Megger, D.; Pankraz, O.; Sitek, B.; Kleinehr, K.; Gerken, Guido; Schlaak, Jörg Friedrich
    ISG15 regulates signalling pathways that are involved in HCV replication
    In: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 690A – 691A
  • Real, C. I.; Bröring, Ruth; Jahn-Hofmann, K.; Ickenstein, L.; John, M.; Kleinehr, K.; Gerken, Guido; Schlaak, Jörg Friedrich
    ISG15 suppression in hepatocytes, mediated by LNP01-formulated sirnas, leads to enhanced responsiveness to interferon in vivo
    In: Journal of Hepatology, Jg. 56, 2012, Nr. Suppl. 2, S. 315
  • Osinusi, Anu; Naggie, Susanna; Poonia, Seerat; Trippler, Martin; Hu, Zonghui; Funk, Emily; Schlaak, Jörg Friedrich; Fishbein, Dawn; Masur, Henry; Polis, Michael; Kottilil, Shyam
    ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV
    In: Journal of Medical Virology, Jg. 84, 2012, Nr. 7, S. 1106 – 1114
    DOI
  • Hubener, A.; Hoyo-Becerra, C.; Real, C. I.; Trippler, M.; Poggenpohl, L.; Gerken, Guido; Schlaak, Jörg Friedrich
    Interferon-Alpha Treatment Induces The Expression of Depression-Related Genes In Vivo and In Vitro
    In: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 1032A – 1032A
  • Ren, Guangxu; Esser, Stefan; Jochum, Christoph; Schlaak, Jörg Friedrich; Gerken, Guido; Schadendorf, Dirk; Dittmer, Ulf; Wu, Gang; Yuan, Zhenghong; Timm, Jörg
    Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1
    In: AIDS, Jg. 26, 2012, Nr. 17, S. 2145 – 2153
    DOI
  • Ertle, Judith; Gerken, Guido; Schlaak, Jörg Friedrich
    Lokalablative Therapien zur Behandlung des hepatozellulären Karzinoms
    In: Der Gastroenterologe, Jg. 7, 2012, Nr. 5, S. 407 – 412
    DOI
  • Zhang, Xiaoyong; Kraft, Anke; Bröring, Ruth; Schlaak, Jörg Friedrich; Dittmer, Ulf; Lu, Mengji
    Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections
    In: Expert Opinion on Drug Discovery, Jg. 7, 2012, Nr. 7, S. 597 – 611
    DOI
  • El Fouly, A.; Ertle, Judith; Mueller, S. P.; Lauenstein, Thomas; Bockisch, Andreas; Gerken, Guido; Dechene, Alexander; Schlaak, Jörg Friedrich
    Predictors of Survival in Patients with Advanced Hepatocellular Carcinoma Treated by Radioemblization using Yttrium-90 Microspheres
    In: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 488A
  • Petersen, J.; Heyne, R.; Mauss, S.; Schlaak, Jörg Friedrich; Schiffelholz, W.; Eisenbach, C.; Hartmann, H.; Wiese, M.; Boeker, K. H.; Loehr, HFF; John, C.; Leuschner, M. S.; Trautwein, C.; Ruppert, S.; Warger, T.; Hueppe, D.
    Profound hepatitis b virus suppression with favorable tolerability by tenofovir in field practice - interim results from the prospective multicenter non-interventional study
    In: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 395A
  • Ertle, Judith; Gerken, Guido; Schlaak, Jörg Friedrich
    Radioembolisation bei fortgeschrittenem hepatozellulärem Karzinom
    In: Visceral Medicine, Jg. 28, 2012, Nr. 5, S. 311 – 316
    DOI
  • Zhang, Xiaoyong; Ma, Zhiyong; Liu, Hongyan; Liu, Jia; Meng, Zhongji; Bröring, Ruth; Yang, Dongliang; Schlaak, Jörg Friedrich; Roggendorf, Michael; Lu, Mengji
    Role of Toll-like receptor 2 in the immune response against hepadnaviral infection
    In: Journal of Hepatology, Jg. 57, 2012, Nr. 3, S. 522 – 528
    DOI
  • Schlaak, Jörg Friedrich; Trippler, Martin; Hoyo-Becerra, Carolina; Erim, Yesim; Kis, Bernhard; Wang, Bo; Scherbaum, Norbert; Gerken, Guido
    Selective Hyper-responsiveness of the Interferon System in Major Depressive Disorders and Depression Induced by Interferon Therapy
    In: PLoS ONE, Jg. 7, 2012, Nr. 6, S. e38668
    DOI (Open Access)
  • Theysohn, Jens; Schlaak, Jörg Friedrich; Müller, Stefan; Ertle, Judith; Schlosser, Thomas Wilfried; Bockisch, Andreas; Lauenstein, Thomas
    Selective internal radiation therapy of hepatocellular carcinoma : Potential hepatopulmonary shunt reduction after sorafenib administration
    In: Journal of Vascular and Interventional Radiology (JVIR), Jg. 23, 2012, Nr. 7, S. 949 – 952
    DOI
  • Johansson, Patricia; Eisele, Lewin; Wymer, Leonie; Hollenbeck, Anita; Kahraman, Alisan; Hilgard, Gudrun; Dührsen, Ulrich; Bröcker-Preuß, Martina; Assert, Roland; Gerken, Guido; Schlaak, Jörg Friedrich; Roß, Rudolf Stefan; Dürig, Jan
    Serum immunoglobulin alterations in patients with chronic hepatitis C
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 142 – 143
  • Jiang, M.; Trippler, M.; Broring, R.; Wu, J.; Gerken, Guido; Lu, M. J.; Schlaak, Jörg Friedrich
    TLR3-Dependent Immunological Properties of Liver Cells are Controlled by Anti-Inflammatory Cytokines Through Modulation of miR-155 Expression
    In: Gastroenterology, Jg. 142, 2012, Nr. 5, Suppl. 1, S. S989 – S990
  • Petersen, J.; Heyne, R.; Mauss, S.; Schlaak, Jörg Friedrich; Schiffelholz, W.; Eisenbach, C.; Hartmann, H.; Wiese, M.; Ruppert, S.; Warger, T.; Huppe, D.; GEMINIS
    Tenofovir DF for chronic Hepatitis B patients in field practice - results from the Geminis German Multicenter Observational Study
    In: Journal of Hepatology, Jg. 56, 2012, Nr. Suppl. 2, S. S212 – S213
  • Bröring, Ruth; Lutterbeck, M.; Kleinehr, K.; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    Toll-like receptor 3 activation of human hepatocytes induces an antiviral state against HCV which is mediated by IFN-lambda but not type I or -II interferons
    In: Hepatology, Jg. 56, 2012, Nr. Suppl. 1, S. 285A
  • Katsounas, Antonios; Trippler, Martin; Kottilil, Shyam; Lempicki, Richard A.; Gerken, Guido; Schlaak, Jörg Friedrich
    Altered expression of SHIP, a toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection
    In: The Journal of Infectious Diseases (JID), Jg. 204, 2011, Nr. 8, S. 1181 – 1185
    DOI
  • Ertle, Judith; Lauenstein, Thomas; Schlaak, Jörg Friedrich
    Benefit of using TARE-Y90 comparing with TACE in the management of primary and secondary liver tumors
    In: European journal of Clinical and Medical Oncology, Jg. 3, 2011, Nr. 1
  • Katsounas, Antonios; Schlaak, Jörg Friedrich; Lempicki, Richard A.
    CCL5 : A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
    In: International Reviews of Immunology, Jg. 30, 2011, Nr. 5-6, S. 366 – 378
    DOI
  • Bröring, Ruth; Montag, Mario; Jiang, Min; Lu, Mengji; Sowa, Jan-Peter; Kleinehr, Kathrin; Gerken, Guido; Schlaak, Jörg Friedrich
    Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state
    In: International Immunology, Jg. 23, 2011, Nr. 9, S. 537 – 544
    DOI
  • Zhang, Xiaoyong; Zhang, Ejuan; Ma, Zhiyong; Pei, Rongjuan; Jiang, Min; Schlaak, Jörg Friedrich; Roggendorf, Michael; Lu, Mengji
    Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1
    In: Hepatology, Jg. 53, 2011, Nr. 5, S. 1476 – 1485
    DOI (Open Access)
  • Ertle, Judith; Dechene, Alexander; Sowa, Jan-Peter; Penndorf, Volker; Herzer, Kerstin; Kaiser, Gernot Maximil; Schlaak, Jörg Friedrich; Gerken, Guido; Syn, Wing-Kin; Canbay, Aliekber
    Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
    In: International Journal of Cancer, Jg. 128, 2011, Nr. 10, S. 2436 – 2443
    DOI
  • Lauenstein, Thomas; Heusner, Till Alexander; Hamami, Monia; Ertle, Judith; Schlaak, Jörg Friedrich; Gerken, Guido; Bockisch, Andreas; Antoch, G.
    Radioembolization of hepatic tumors : Flow redistribution after the occlusion of intrahepatic arteries
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Jg. 183, 2011, Nr. 11, S. 1058 – 1064
    DOI
  • Bröring, Ruth; Lu, Mengji; Schlaak, Jörg Friedrich; Schlaak, Joerg F.
    Role of Toll-like receptors in liver health and disease
    In: Clinical Science, Jg. 121, 2011, Nr. 10, S. 415 – 426
    DOI
  • Zhang, X.; Zhang, E.; Meng, Z.; Ma, Z.; Schlaak, Jörg Friedrich; Lu, Mengji
    110 Modulation of HBV replication and cellular gene expression by microrna-1
    In: Journal of Hepatology, Jg. 52, 2010, Nr. Suppl. 1, S. S49 – S50
    DOI
  • Trippler, M.; Bröring, Ruth; Poggenpohl, L.; Gerken, Guido; Schlaak, Jörg Friedrich
    1176 Induction of unfavorable isgs in the liver of HCV patients is due to hyper-responsiveness to IFNS and does not correlate with local IL-28 expression
    In: Journal of Hepatology, Jg. 52, 2010, Nr. Suppl. 1, S. S454 – S455
    DOI
  • Bröring, Ruth; John, M.; Kleinehr, K.; Sowa, Jan-Peter; Bucchi, A.; Gerken, Guido; Schlaak, Jörg Friedrich
    445 The activation of the hepatic immune system by sirnas is differently controlled by chemical modifications and may involve endosomal toll-like receptors
    In: Journal of Hepatology, Jg. 52, 2010, Nr. Suppl. 1, S. S180
    DOI
  • Jiang, M.; Trippler, M.; Bröring, Ruth; Poggenpohl, L.; Wu, J.; Roggendorf, Michael; Gerken, Guido; Lu, Mengji; Schlaak, Jörg Friedrich
    627 HBV suppresses TLR signaling and the crosstalk to the adaptive immune system in murine and human cells
    In: Journal of Hepatology, Jg. 52, 2010, Nr. Suppl. 1, S. S246
    DOI
  • Johansson, Patricia; Maldonado de Dechene, E.; Eisele, Lewin; Kieruzel, Sabrina; Horn, Peter; Schmücker, U.; Vetter, Irina; Dührsen, Ulrich; Gerken, Guido; Dürig, Jan; Schlaak, Jörg Friedrich
    705 Increased prevalence of monoclonal b lymphocytosis in patients with chronic Hepatitis C
    In: Journal of Hepatology, Jg. 52, 2010, Nr. Suppl. 1, S. S274
    DOI
  • Atreya, R.; Mudter, J.; Finotto, S.; Mullberg, J.; Jostock, T.; Wirtz, S.; Schutz, M.; Bartsch, B.; Holtmann, Marianne; Becker, C.; Strand, D.; Czaja, J.; Schlaak, Jörg Friedrich; Lehr, H. A.; Autschbach, F.; Schurmann, G.; Nishimoto, N.; Yoshizaki, K.; Ito, H.; Kishimoto, T.; Galle, P. R.; Rose-John, S.; Neurath, M. F.
    Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation : Evidence in Crohn disease and experimental colitis in vivo (vol 6, pg 583, 2000)
    In: Nature Medicine, Jg. 16, 2010, Nr. 11, S. 1341
    DOI
  • Erim, Yesim; Tagay, Sefik; Beckmann, Mingo; Bein, Sabine; Cicinnati, Vito; Beckebaum, Susanne; Senf, Wolfgang; Schlaak, Jörg Friedrich
    Depression and protective factors of mental health in people with hepatitis C : A questionnaire survey
    In: International Journal of Nursing Studies, Jg. 47, 2010, Nr. 3, S. 342 – 349
    DOI
  • Benko, Tamas; Frede, Stilla; Gu, Yanli; Best, Jan; Baba, Hideo Andreas; Schlaak, Jörg Friedrich; De Groot, Herbert; Fandrey, Joachim; Rauen, Ursula
    Glycine pretreatment ameliorates liver injury after partial hepatectomy in the rat
    In: Journal of Investigative Surgery, Jg. 23, 2010, Nr. 1, S. 12 – 20
    DOI
  • Burbelo, Peter D.; Kovacs, Joseph A.; Ching, Kathryn H.; Issa, Alexandra T.; Iadarola, Michael J.; Murphy, Alison A.; Schlaak, Jörg Friedrich; Masur, Henry; Polis, Michael A.; Kottilil, Shyam
    Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients
    In: The Journal of Infectious Diseases (JID), Jg. 202, 2010, Nr. 6, S. 894 – 898
    DOI
  • Bröring, Ruth; Zhang, Xiaozhen; Kottilil, Shyam; Trippler, Martin; Jiang, Min; Lu, Mengji; Gerken, Guido; Schlaak, Jörg Friedrich
    The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response
    In: Gut, Jg. 59, 2010, Nr. 8, S. 1111 – 1119
    DOI
  • Heibges, A.; Kitze, B.; Staudt, A.; Mösges, R.; Schlaak, Jörg Friedrich; Wanner, C.; Meeßen, A.; Klingel, R.
    Therapeutische Apherese 2008 : Themen des 8. Apherese-Therapie-Seminars am 5. Dezember 2008 in Berlin
    In: Nieren- und Hochdruckkrankheiten, Jg. 39, 2010, Nr. 1, S. 25 – 32
  • Wu, Jun; Meng, Zhongji; Jiang, Min; Zhang, Ejuan; Trippler, Martin; Bröring, Ruth; Bucchi, Agnes; Krux, Frank; Dittmer, Ulf; Yang, Dongliang; Roggendorf, Michael; Gerken, Guido; Lu, Mengji; Schlaak, Jörg Friedrich
    Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific
    In: Immunology, Jg. 129, 2010, Nr. 3, S. 363 – 374
    DOI
  • Abendroth, A.; Klein, R.; Schlaak, Jörg Friedrich; Metz, Klaus; Dobos, Gustav; Langhorst, Jost
    Imposanter Befund einer Melanosis Coli nach jahrzehntelangem Abusus von Anthrachinonderivaten : Ein Risikofaktor für kolorektale Neoplasien?
    In: Zeitschrift für Gastroenterologie, Jg. 47, 2009, Nr. 6, S. 579 – 582
    DOI
  • Bockhorn, Maximilian; Fingas, Christian; Rauen, Ursula; Canbay, Aliekber; Sotiropoulos, Georgios; Frey, Ulrich; Sheu, Sien-Yi; Wohlschläger, Jeremias; Broelsch, Christoph E.; Schlaak, Jörg Friedrich
    Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation
    In: Transplantation, Jg. 86, 2008, Nr. 11, S. 1578 – 1585
    DOI
  • Bockhorn, Maximilian; Benkö, Tamasz; Opitz, Bettina; Sheu, Sien-Yi; Sotiropoulos, Georgios; Schlaak, Jörg Friedrich; Broelsch, Christoph E.; Lang, Hauke
    Impact of hepatic vein deprivation on liver regeneration and function after major hepatectomy
    In: Langenbeck's Archives of Surgery, Jg. 393, 2008, Nr. 4, S. 527 – 533
    DOI
  • Bockhorn, Maximilian; Frilling, Andreja; Benkö, Tamas; Best, Jan; Sheu, Sien-Yi; Trippler, M.; Schlaak, Jörg Friedrich; Broelsch, C.E.
    Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy
    In: European Surgical Research, Jg. 39, 2007, Nr. 1, S. 58 – 63
    DOI
  • Erim, Yesim; Beckmann, Mingo; Valentin-Gamazo, Camino; Malago, Massimo; Frilling, Andrea; Schlaak, Jörg Friedrich; Gerken, Guido; Broelsch, Christoph E.; Senf, Wolfgang
    Quality of life and psychiatric complications after adult living donor liver transplantation
    In: Liver Transplantation, Jg. 12, 2006, Nr. 12, S. 1782 – 1790
    DOI (Open Access)

    • Abstracts

  • Zhenhua, Zhu; Trippler, Martin; Real, Catherine Isabell; Werner, Melanie; Kemper, Thekla; Baba, Hideo Andreas; Treckmann, Jürgen-Walter; Paul, A.; Gerken, Guido; Schlaak, Jörg Friedrich; Lu, Mengji; Bröring, Ruth
    Hepatitis B virus entry in primary human hepatocytes initiates toll-like receptor 2-dependent immune signaling
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 68, 2018, Nr. Suppl. 1, S. 793
    DOI
  • Bröring, Ruth; Zhang, Z.; Trippler, M.; Real, C.; Werner, M.; Gerken, Guido; Schlaak, Jörg Friedrich; Lu, Mengji
    Hepatitis B virus activates toll-like receptor 2 signaling upon infection of primary human hepatocytes
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 64, 2016, Nr. 2, Suppl., S. S394
    DOI
  • Real, C.; Werner, M.; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich; Vaillant, A.; Bröring, Ruth
    Nucleic Acid-Based Polymers Effective against Hepatitis B Virus Infection in Patients Do Not Harbour Immune Stimulatory Properties in Primary Isolated Blood or Liver Cells
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 64, 2016, Nr. 2, Suppl., S. S395
    DOI
  • Lutterbeck, M.; Real, C. I.; Skibbe, K.; Timm, Jörg; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich; Bröring, Ruth
    All-in-one liver cell preparation : high quality of functional primary human hepatocytes, liver sinusoidal endothelial cells, Kupffer cells and hepatic stellate cells
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 60, 2014, Nr. Suppl. 1, S. 814A
    DOI
  • Hoyo-Becerra, C.; Liu, Z. J.; Hermann, Dirk M.; Schlaak, Jörg Friedrich
    New mouse model mimicking IFN-alpha-related depression in hepatitis C virus infected patients
    Joint Congress of European Neurology 31 May–3 June 2014 Istanbul, Turkey,
    In: Journal of Neurology. Berlin; Leipzig: Springer, Jg. 261, 2014, Nr. Suppl. 1, S. 236
    DOI
  • Hoyo-Becerra, C.; Liu, Z. J.; Hermann, Dirk M.; Schlaak, Jörg Friedrich
    New mouse model mimicking IFN-alpha-related depression in hepatitis C virus infected patients
    Joint Congress of European Neurology, Istanbul, Turkey, May 2014,
    In: European Journal of Neurology. Hoboken: Wiley, Jg. 21, 2014, Nr. Suppl. 1, S. 349
    DOI
  • Nel, I.; Baba, Hideo Andreas; Howner, A.; Weber, Frank; Sitek, B.; Eisenacher, M.; Meyer, H. E.; Gerken, Guido; Schlaak, Jörg Friedrich; Hoffmann, Andreas-Claudius
    Presence of circulating tumor cells with stem cell characteristics predicts response to SIRT in hepatocellular carcinoma
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 53
    DOI
  • Weber, Frank; Wellenberg, N.; Ahrens, M.; Swoboda, S.; Trippler, M.; Sitek, B.; Hoffmann, A.; Meyer, H.; Baba, Hideo Andreas; Eisenacher, M.; Schlaak, Jörg Friedrich; Paul, Andreas
    Sex Hormone Binding Globulin Is Deregulated in Aggressive Hepatocellular Carcinoma and Predicts Early Tumor Recurrence
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 50
    DOI
  • Nel, Ivonne; Ertlel, Judith M.; Baba, Hideo Andreas; Weber, Frank; Sitek, Barbara; Stephan, Christian; Meyer, Helmut; Schlaak, Jörg Friedrich; Hoffmann, Andreas-Claudius
    A novel method for the detection of different subgroups of circulating tumor cells in patients with hepatocellular carcinoma
    63rd Annual Meeting of the American Association for the Study of Liver Diseases, The Liver Meeting 2012, November 9-13, 2012, Boston, Mass., USA,
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 56, 2012, Nr. Suppl. 1, S. 457A
    DOI
  • Zhang, X.; Liu, H.; Wang, B.; Ma, Z.; Zhang, J.; Yang, D.; Schlaak, Jörg Friedrich; Roggendorf, Michael; Lu, Mengji
    Epigenetic control of Hepatitis B virus replication and farnesoid X receptor alpha expression by histone deacetylases 3
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Suppl. 2, S. S17
    DOI
  • Jiang, M.; Trippler, M.; Bröring, Ruth; Poggenpohl, L.; Gerken, Guido; Lu, Mengji; Schlaak, Jörg Friedrich
    Hepatitis B virus surface antigen suppresses innate and adaptive immune responses of murine and human liver cells
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S174
    DOI
  • Hoyo-Becerra, Carolina; Hübener, A.; Trippler, M.; Poggenpohl, L.; Gerken, Guido; Schlaak, Jörg Friedrich
    Interferon-a treatment differentially regulates the expression of interferon-inducible genes in hippocampal and prefrontal cortex neurons
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S348 – S349
    DOI
  • Ziegler, S.; Bröring, Ruth; Nahmias, Yaakov; Schlaak, Jörg Friedrich; Timm, Jörg
    Primary human hepatocytes inhibit expansion of virus-specific CD8+ T cells in vitro
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S318
    DOI
  • Jiang, M.; Trippler, M.; Bröring, Ruth; Wu, J.; Zhang, E.; Zhang, X.; Gerken, Guido; Lu, Mengji; Schlaak, Jörg Friedrich
    TLR-3 dependent immunological properties of liver cells are controlled by anti-inflammatory cytokines through modulation of MIR-155 expression
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S302 – S303
    DOI
  • Liu, J.; Jiang, M.; Ma, Z.; Schlaak, Jörg Friedrich; Roggendorf, Michael; Lu, Mengji
    TLR1/2 ligand stimulated mouse liver endothelial cells produce IL-12 and trigger CD8+ T-Cell immunity
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Supplement 2, S. S311
    DOI
  • Wang, B.; Schlaak, Jörg Friedrich
    TLR3 induced expression of rantes modulates the function of activated primary hepatic stellate cells
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Suppl. 2, S. S162
    DOI
  • Bröring, Ruth; Lutterbeck, M.; Kleinehr, K.; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    Toll-like receptor-activated human hepatocytes produce inflammatory cytokines and type III interferons, resulting in IFN-γ-mediated suppression of HCV in vitro
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 56, 2012, Nr. Suppl. 2, S. S56
    DOI
  • Real, Catherine; Bröring, Ruth; Ickenstein, Ludger M.; Jahn-Hofmann, Kerstin; John, Matthias J.; Kleinehr, Kathrin; Gerken, Guido; Schlaak, Jörg Friedrich
    Activation of the Hepatic Immune System by application of Sirnas in Vivo can be controlled by Chemical Ribose Modifications of the Sirna Backbone
    The 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011,
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 54, 2011, Nr. Suppl. 1, S. 520A
    DOI
  • Naggie, S.; Osinusi, A.; Katsounas, Antonios; Lempicki, Richard; Herrmann, E.; Shivakumar, B.; Thompson, A.; Clark, Paul; Patel, K.; Muir, A.; Mchutchison, J.; Goldstein, D.; Schlaak, Jörg Friedrich; Masur, H.; Polis, M.; Kottilil, S.
    Dysregulation of host innate immunity in HCV genotype 1 infected IL28B CT/TT haplotype patients with depressed viral kinetics and therapeutic response
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S526 – S527
    DOI
  • Pankraz, Olessja; Bröring, Ruth; Trippler, M.; Gerken, Guido; Schlaak, Jörg Friedrich
    ISG15 and microrna-122 regulate hepatitis C virus replication independently
    46th annual meeting of the European Association for the Study of the Liver ; Berlin, 30 March-3 April 2011,
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S124
    DOI
  • Osinusi, Anu; Naggie, Susanna; Poonia, Seerat; Trippler, Martin; Hu, Zonghui; Funk, Emily; Schlaak, Jörg Friedrich; Fishbein, Dawn; Masur, Henry; Polis, Michael A.; Kottilil, Shyam
    ITPA Gene Polymorphisms Significantly Affect Haemoglobin Decline and Treatment outcomes in HIV/HCV Co-Infected Patients
    The 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011,
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 54, 2011, Nr. Suppl. 1, S. 854A
    DOI
  • El Fouly, Amr; Schlaak, Jörg Friedrich; El Dorry, Ahmed; Shaker, Mohamad K.; Dechene, Alexander; Abdella, Heba; Ertle, Judith; Müller, Stefan; Barakat, Eman M.; Lauenstein, Thomas; Antoch, Gerald; Bockisch, Andreas; Gerken, Guido
    In Intermediate stage Hepatocellular Carcinoma : Radioembolization weith YTTRIUM-90 or Chemobolization?
    The 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011,
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 54, 2011, Nr. Suppl. 1, S. 1419A
    DOI
  • Real, Catherine I.; Broring, Ruth; John, Matthias; Kleinehr, Kathrin; Gerken, Guido; Schlaak, Jörg Friedrich
    In Vivo Treatment With Nanolipid-Formulated siRNAs Targeting ISG15 Leads to Enhanced TLR-Induced Expression of Interferon-Sensitive Genes in Hepatocytes
    In: Gastroenterology. Amsterdam: Elsevier, Jg. 140, 2011, Nr. 5 Suppl. 1, S. S928
    DOI
  • Trippler, Martin; Poggenpohl, L.; Gerken, Guido; Schlaak, Jörg Friedrich
    In chronic hepatitis B innate immune responses in peripheral blood mononuclear cells correlate with HBsAg serum titers and are modulated by antiviral therapy
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S446
    DOI
  • Radunz, Sonia; Sotiropoulos, Georgios; Schlaak, Jörg Friedrich; Bockisch, Andreas; Lauenstein, Thomas; Baba, Hideo Andreas; Paul, Andreas; Treckmann, Jürgen-Walter
    Liver transplantation after radioembolization with Yttrium-90 microspheres
    15th Congress of the European Society for Organ Transplantation & 22nd Annual Conference of the British Society for Histocompatibility & Immunogenetics. September 4-7, 2011. Glasgow, United Kingdom,
    In: Transplant International. Lausanne: Frontiers Media, Jg. 24, 2011, Nr. Suppl. 2, S. 314
    DOI
  • Zhang, X.; Ma, Z.; Wu, C.; Zhang, E.; Bröring, Ruth; Schlaak, Jörg Friedrich; Roggendorf, Michael; Lu, Mengji
    Modulation of HBV replication by cell cycle and differentiation related micrornas
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S448 – S449
    DOI
  • Erhardt, Andreas; Link, Ralph; Moeller, Bernd; Gelbmann, Cornelia; Wettstein, Matthias; Zeuzem, Stefan; Bauditz, Juergen; Stolzel, Ulrich; Hueppe, Dietrich; Arnold, Joachim C.; Krohn, Ulrike; Schlaak, Jörg Friedrich; Spengler, Ulrich; Haussinger, Dieter
    PEG-Interferon-ALFA2A/Ribavirin +/- Phlebotomy in HCV GT 1 Patients : Final Results of the Kapri Trial
    The 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011,
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 54, 2011, Nr. Suppl. 1, S. 487A – 488A
    DOI
  • Schuchmann, Marcus; Kittner, Jens M.; Schlaak, Jörg Friedrich; Klass, Dietmar M.; Eisenbach, Christoph; Berg, Thomas; Trautwein, Christian; Gunther, Rainer; Zeuzem, Stefan; Gosseringer, Roger; Ehrlich, Anne; Neumann, Konrad; Wachtlin, Daniel; Boecher, Wulf O.; Galle, Peter R.
    Safety,Tolerability and Hepatitis C Viral Kinetics during Treatment with All-Trans Retinoic Plus Pegylated interferon and Ribavirin in Patients with previous Non-Response : Results of the Atraction Study
    The 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011,
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 54, 2011, Nr. Suppl. 1, S. 1001A
    DOI
  • Ertle, Judith; Wichert, Marc; Kuper, R.; Hilgard, Philip Alexander; Gerken, Guido; Schlaak, Jörg Friedrich
    Sensitivity and Specificity of Apha-Feto Protein (AFP), Lens Culinaris Agglutinin-Reactive AFP (AFP-L3) and Des-Gamma-Carboxyprothrombin (DCP) as Tumor Markers in Patients with Hepatocellular Carcinoma (HCC)
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S384
    DOI
  • Real, Catherine; Bröring, Ruth; Ickenstein, Ludger M.; Jahn-Hofmann, Kerstin; John, Matthias J.; Kleinehr, Kathrin; Gerken, Guido; Schlaak, Jörg Friedrich
    Sirna-Induced Supression of ISG15 in Vivo Leads to enhanced Responsiveness to Ebdogneous interferon in Hepatocytes
    The 62nd Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2011,
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 54, 2011, Nr. Suppl. 1, S. 545A – 546A
    DOI
  • Broring, Ruth; Kleinehr, Kathrin; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    The Toll-Like Receptor Mediated Induction of Interferons is Not Impaired in Primary Liver Cells From HCV-Positive Patients
    In: Gastroenterology. Amsterdam: Elsevier, Jg. 140, 2011, Nr. 5 Suppl. 1, S. S971
    DOI
  • Real, Catherine I.; Bröring, Ruth; Jahn-Hofmann, K.; Ickenstein, L.; John, M.; Kleinehr, K.; Schlaak, Jörg Friedrich; Gerken, Guido
    The non-specific activation of liver cells by therapeutically applicated sirnas is minimized by chemical ribose modificatons of the sirna backbone
    46th annual meeting of the European Association for the Study of the Liver ; Berlin, 30 March-3 April 2011,
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S124
    DOI
  • Bröring, Ruth; Kleinehr, K.; Paul, Andreas; Gerken, Guido; Schlaak, Jörg Friedrich
    The toll-like receptor mediated production of interferons and immunomodulatory cytokines is not impaired in primary liver cells from HCV-positive patients
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 54, 2011, Nr. Suppl. 1, S. S309
    DOI
  • Gu, Yanli; Sowa, Jan-Peter; Paul, Andreas; Schlaak, Jörg Friedrich
    139 Liver regeneration and survival after subtotal hepatectomy in a fatty liver model is improved by vegf
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 52, 2010, Nr. Suppl. 1, S. S62 – S63
    DOI
  • Jiang, M.; Wu, J.; Zhang, E.; Meng, Z.; Trippler, M.; Bröring, Ruth; Roggendorf, Michael; Gerken, Guido; Lu, Mengji; Schlaak, Jörg Friedrich
    446 HCV/TLR3- dependent innate and adaptive immune functions of non-parenchymal liver cells are controlled by interleukin-10 and transforming growth factor beta
    In: Journal of Hepatology. Amsterdam; Copenhagen; Oxford: Elsevier, Jg. 52, 2010, Nr. Suppl. 1, S. S180
    DOI
  • Johansson, Patricia; Hollenbeck, Anita; Horn, Peter; Dührsen, Ulrich; Gerken, Guido; Dürig, Jan; Schlaak, Jörg Friedrich
    Polyclonal B-Cell activation and Expansion of Monoclonal B Cells in the Peripheral Blood of Patients with Chronic Hepatitis C
    In: Hepatology. Hoboken: Wiley & Sons, Jg. 52, 2010, Nr. Suppl. 1, S. 740A
    DOI
  • Johansson, Patricia; Hollenbeck, Anita; Klein-Hitpaß, Ludger; de Dechene, Maldonado E; Eisele, Lewin; Kieruzel, Sabrina; Horn, Peter; Schmücker, Ute; Vetter, Ina; Gerken, Guido; Dührsen, Ulrich; Dürig, Jan; Schlaak, Jörg Friedrich
    Prevalence of B cell lymphoproliferative disorders in patients with chronic hepatitis C (CHC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010, pp 109–206,
    In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 157
    DOI
  • Haag, Sebastian; Trippler, M.; Poggenpohl, L.; Lechtermann, C.; Gerken, Guido; Schlaak, Jörg Friedrich
    Type-I IFN system is activated in patients with irritable bowel syndrome
    Australian Gastroenterology Week 2010,
    In: Journal of Gastroenterology and Hepatology. Oxford: Wiley-Blackwell, Jg. 25, 2010, Nr. Suppl. 3, S. A105 – A105
    DOI